Adam Corken Institution-verified

Sourced from institutional research profiles (UAMS TRI or ARA).

Associate Staff Scientist

UAMS

Last publication 2026 Last refreshed 2026-05-23

staff

10 h-index 22 pubs 1,103 cited

Research Areas

Links

ORCID Research Group UAMS TRI Profile

Edit your profile

OverviewAI-generated summary

Adam Corken's research primarily investigates the role of platelets in chronic kidney disease (CKD), with a focus on their contribution to inflammatory dysregulation. His work has explored how platelet activity and purinergic receptors are implicated in the progression of CKD, particularly in patients with advanced stages. Corken has also examined the comparative effects of antiplatelet medications, such as ticagrelor and clopidogrel, on platelet aggregation and inflammation in CKD patients.

His research extends to other areas, including the influence of maternal obesity on perivascular adipose tissue and associated immune cells, and the protective role of platelet glycoprotein Ibα in radiation exposure. Additionally, Corken has investigated how diet, such as a Western diet, can modify platelet activation profiles in mice, and how platelets impact leukocyte composition within perivascular adipose tissue. Corken holds an h-index of 10 with 21 total publications and over 1,000 citations. He collaborates with researchers at the University of Arkansas for Medical Sciences, including Keshari Thakali and Jerry Ware.

Metrics

h-index: 10
Publications: 22
Citations: 1,103

Selected Publications

Postweaning diet affects offspring metabolic outcomes more than maternal diet in male and female mice (2026)

DOI OpenAlex
Platelets Modulate Leukocyte Population Composition Within Perivascular Adipose Tissue (2025)

1 citation DOI OpenAlex
Western Diet Modifies Platelet Activation Profiles in Male Mice (2024)

2 citations DOI OpenAlex
Platelets, inflammation, and purinergic receptors in chronic kidney disease (2024)

12 citations DOI OpenAlex
Ticagrelor inhibits platelet aggregation and reduces inflammatory burden more than clopidogrel in patients with stages 4 or 5 chronic kidney disease (2023)

11 citations DOI OpenAlex
Platelet-Dependent Inflammatory Dysregulation in Patients with Stages 4 or 5 Chronic Kidney Disease: A Mechanistic Clinical Study (2022)

13 citations DOI OpenAlex
Maternal Obesity Programming of Perivascular Adipose Tissue and Associated Immune Cells: An Understudied Area With Few Answers and Many Questions (2022)

6 citations DOI OpenAlex
Platelet glycoprotein Ibα provides radiation protection (2021)

4 citations DOI OpenAlex
Role of Platelets in Chronic Kidney Disease (2021)

43 citations DOI OpenAlex